Andrew J. Wang

Array ( [id] => 4303982 [patent_doc_number] => 06251873 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-26 [patent_title] => 'Antisense compounds to CD14' [patent_app_type] => 1 [patent_app_number] => 9/180437 [patent_app_country] => US [patent_app_date] => 1998-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 29439 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/251/06251873.pdf [firstpage_image] =>[orig_patent_app_number] => 180437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4045927 [patent_doc_number] => 05968750 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-19 [patent_title] => 'Humanized green fluorescent protein genes and methods' [patent_app_type] => 1 [patent_app_number] => 9/169605 [patent_app_country] => US [patent_app_date] => 1998-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 11 [patent_no_of_words] => 34321 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/968/05968750.pdf [firstpage_image] =>[orig_patent_app_number] => 169605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1549689 [patent_doc_number] => 06399297 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-04 [patent_title] => 'Antisense modulation of expression of tumor necrosis factor receptor-associated factors (TRAFs)' [patent_app_type] => B1 [patent_app_number] => 09/167109 [patent_app_country] => US [patent_app_date] => 1998-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20768 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/399/06399297.pdf [firstpage_image] =>[orig_patent_app_number] => 09167109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4071451 [patent_doc_number] => 05965370 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-12 [patent_title] => 'Antisense modulation of RhoG expression' [patent_app_type] => 1 [patent_app_number] => 9/161015 [patent_app_country] => US [patent_app_date] => 1998-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18253 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/965/05965370.pdf [firstpage_image] =>[orig_patent_app_number] => 161015 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1550460 [patent_doc_number] => 06346613 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-12 [patent_title] => 'Composition and method for enhancing paracellular transport across cell layers' [patent_app_type] => B1 [patent_app_number] => 09/160496 [patent_app_country] => US [patent_app_date] => 1998-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6912 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/346/06346613.pdf [firstpage_image] =>[orig_patent_app_number] => 09160496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3922761 [patent_doc_number] => 05945290 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-31 [patent_title] => 'Antisense modulation of RhoA expression' [patent_app_type] => 1 [patent_app_number] => 9/156424 [patent_app_country] => US [patent_app_date] => 1998-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18466 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/945/05945290.pdf [firstpage_image] =>[orig_patent_app_number] => 156424 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4140164 [patent_doc_number] => 06030786 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-29 [patent_title] => 'Antisense modulation of RhoC expression' [patent_app_type] => 1 [patent_app_number] => 9/156807 [patent_app_country] => US [patent_app_date] => 1998-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18429 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/030/06030786.pdf [firstpage_image] =>[orig_patent_app_number] => 156807 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3977287 [patent_doc_number] => 05948626 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-07 [patent_title] => 'Method of detecting human phospholipase inhibitor' [patent_app_type] => 1 [patent_app_number] => 9/153751 [patent_app_country] => US [patent_app_date] => 1998-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 18636 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/948/05948626.pdf [firstpage_image] =>[orig_patent_app_number] => 153751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4140255 [patent_doc_number] => 06030791 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-29 [patent_title] => 'Antibody for a homolog of rat elastase IV derived from human pancreas' [patent_app_type] => 1 [patent_app_number] => 9/153304 [patent_app_country] => US [patent_app_date] => 1998-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 4 [patent_no_of_words] => 12483 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/030/06030791.pdf [firstpage_image] =>[orig_patent_app_number] => 153304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4273201 [patent_doc_number] => 06280938 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-28 [patent_title] => 'SCA7 gene and method of use' [patent_app_type] => 1 [patent_app_number] => 9/135994 [patent_app_country] => US [patent_app_date] => 1998-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 20 [patent_no_of_words] => 14350 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/280/06280938.pdf [firstpage_image] =>[orig_patent_app_number] => 135994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1551663 [patent_doc_number] => 06399754 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-04 [patent_title] => 'Sugar modified oligonucleotides' [patent_app_type] => B1 [patent_app_number] => 09/135202 [patent_app_country] => US [patent_app_date] => 1998-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 31422 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/399/06399754.pdf [firstpage_image] =>[orig_patent_app_number] => 09135202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4154264 [patent_doc_number] => 06156513 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-05 [patent_title] => 'Oligmers which inhibit expression of collagen genes' [patent_app_type] => 1 [patent_app_number] => 9/130888 [patent_app_country] => US [patent_app_date] => 1998-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 23 [patent_no_of_words] => 15717 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/156/06156513.pdf [firstpage_image] =>[orig_patent_app_number] => 130888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4135552 [patent_doc_number] => 06015676 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-18 [patent_title] => 'Method for knocking out gene transcripts by covalently binding of an anti-sense probe' [patent_app_type] => 1 [patent_app_number] => 9/127368 [patent_app_country] => US [patent_app_date] => 1998-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4611 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/015/06015676.pdf [firstpage_image] =>[orig_patent_app_number] => 127368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4083182 [patent_doc_number] => 06025140 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-15 [patent_title] => 'Membrane-permeable constructs for transport across a lipid membrane' [patent_app_type] => 1 [patent_app_number] => 9/116294 [patent_app_country] => US [patent_app_date] => 1998-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11860 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/025/06025140.pdf [firstpage_image] =>[orig_patent_app_number] => 116294 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4186738 [patent_doc_number] => 06042846 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-28 [patent_title] => 'Liposomal phosphodiester, phosphorothioate, and p-ethoxy oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 9/112869 [patent_app_country] => US [patent_app_date] => 1998-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 4357 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/042/06042846.pdf [firstpage_image] =>[orig_patent_app_number] => 112869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4043614 [patent_doc_number] => 05912130 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-15 [patent_title] => 'Human Homolog of the rat G protein gamma-5 subunit' [patent_app_type] => 1 [patent_app_number] => 9/111348 [patent_app_country] => US [patent_app_date] => 1998-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18940 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/912/05912130.pdf [firstpage_image] =>[orig_patent_app_number] => 111348 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4062357 [patent_doc_number] => 06007995 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-28 [patent_title] => 'Antisense inhibition of TNFR1 expression' [patent_app_type] => 1 [patent_app_number] => 9/106038 [patent_app_country] => US [patent_app_date] => 1998-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19729 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/007/06007995.pdf [firstpage_image] =>[orig_patent_app_number] => 106038 [rel_patent_id] =>[rel_patent_doc_number] =>)